Eli Lilly will begin offering its popular new weight-loss drug Zepbound in vials—in addition to standard injection-pen ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Now, Eli Lilly is looking to lower that cost a little ... But the classic Zepbound was given with an auto-injector that ...

In August 2024, Eli Lilly announced that Zepbound would be ... offers comes in a single-dose vial rather than as an auto-injector pen, also called a Zepbound pen. The vial doses available are ...

The world’s biggest drugmaker Eli Lilly has forecast that profits for the year will beat expectations, after two choppy quarters when disappointing sales of its blockbuster weight-loss drugs led to ...

Eli Lilly is just weeks away from launching ... the first major market to be supplied with the drug in the multi-shot pen injector format. Like the earlier single-dose version, which was approved ...

Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...

The EMA’s human medicines advisory committee has recommended approval of Eli Lilly ... however with the pen-injector not due to hit the market until next year, so Lilly has first-mover advantage.